28.8 C
Vientiane
Tuesday, July 1, 2025
spot_img
Home Blog Page 1034

Yaber Celebrates a Joyful Start to 2025 with T2 Projector and Google Pixel 9 Giveaway

HONG KONG, Jan. 22, 2025 /PRNewswire/ — Yaber, a prominent name in the entertainment projector industry, has teamed up with 9to5Google and Google to mark the start of 2025 with an exclusive giveaway. This collaboration features the Google Pixel 9 and Yaber T2 projector, offering customers a unique opportunity to experience cutting-edge technology from two innovative brands.

Yaber celebrates 2025 with T2 projector and Google Pixel 9 giveaway
Yaber celebrates 2025 with T2 projector and Google Pixel 9 giveaway

Yaber has gained recognition in the entertainment projector market for its innovative designs and premium features. In 2024, it launched the K3 home theater and T2 outdoor portable series, both acclaimed for winning prestigious honors, including MUSE, American, and French design awards, as well as the Visual Grand Prix (VGP) award, alongside their JBL audio integration. At CES 2025, Yaber introduced the K300s, the world’s most compact ultra-short throw laser projector, earning a CES 2025 Innovation Award and Best of CES 2025 recognition from media outlets like Android Authority, Stuff, Trusted Reviews, and Yanko Design.

Enter now to participate in the giveaway on 9to5Google:

  • Sign up by entering your name and email.
  • Share the giveaway and follow Yaber on Facebook and Twitter to boost your chances.

Entries close on February 16, 2025. 

About Yaber 

Founded in 2018, Yaber redefined home entertainment by introducing the world’s first entertainment projector, pioneering a new category in the industry. Today, its innovative projectors have delivered immersive experiences to users in over 120 countries, making Yaber a trusted name in global home entertainment.

The letter “Y” in Yaber embodies the youthful vigor and innovative spirit of Generation Y. It’s not just a symbol, but a unique representation of youth identity and attitude towards life, infusing the brand with rich cultural connotations of youthfulness within simplicity. 

Committed to excellence, Yaber has been pushing the boundaries of audiovisual innovation, crafting projectors that inspire richer, more vibrant lifestyles. Its achievements are recognied with prestigious accolades, including the Red Dot, IDEA, VGP, and CES Innovation Awards.

For the latest updates, visit www.yaber.com as Yaber continues to redefine excellence in entertainment.

JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital Pathology

First shared at a recent Japanese Society of Digital Pathology meeting, the company is forging a global alliance with a leading US medical institution and other organizations to harness technology for better patient care and outcomes in oncology.

TAIPEI, Jan. 22, 2025 /PRNewswire/ — JelloX Biotech Inc., a Taiwan-based startup focused on cancer pathology, is unveiling its vision for AI and 3D digital pathology to advance patient-centered care. The vision was first detailed publicly by Dr. Yen-Yin Lin, CEO of JelloX, during the August 2024 Annual Meeting of the Japanese Society of Digital Pathology. JelloX continues to distinguish itself as an early adopter of AI and 3D imaging applied to cancer pathology.

“Technological advancements and the recent surge in AI have reshaped the future of healthcare, enabling the extraction of valuable insights that will have real benefits for patients,” shared Dr. Lin. “3D pathology can offer at least 50 times more information than conventional 2D methods, providing pathologists with a more comprehensive understanding of a tumor’s biology. The power of such a diagnostic tool lies in its ability to help pathologists stratify and personalize, matching the right patients with the right treatment at the right time. This ultimately leads to better prognosis, quality of life, and more patient-centered care.”

Improving patient-centered care with technology

JelloX has previously estimated that 40% of cancer patients can benefit from AI-analyzed 3D imaging for pathology by expanding feasibility of treatment options like immunotherapy. Due to the complexity of cancer and variability between cases, these technologies hold significant promise for oncology, particularly in addressing the challenge of limited information from conventional methods. With the increased sampling rate via 3D imaging analyzed by AI, pathologists have more actionable insights regarding the tumor, assisting them in making a wholistic diagnosis.

Patients who were previously excluded from immunotherapy due to undetected biomarker expressions, resulting from the limitations of current techniques, may now have a renewed opportunity. With its improved sensitivity, 3D pathology can not only identify cases previously classified as “false negatives” but also enable early cancer detection. This allows for earlier treatment initiation, leading to an improved quality of life for patients.

For healthcare providers, this means matching the right patients to the right drugs at the right time. For patients, more precision for diagnosis, treatment, and timing means lowered risk of misdiagnosis, minimized patient costs, and better prognosis—ultimately to more patient-centered care and better quality of life.

A visionary new platform

Dr. Lin continued: “The fight against cancer is not a one-on-one battle, so partnerships are crucial to accomplish this. JelloX has embraced collaboration across countries and industries to build an AI-powered 3D pathology platform together.”

In collaboration with a leading US medical center and other partners, JelloX is developing a platform that can address multiple pain points for patients and the healthcare industry. The platform will leverage JelloX’s software, MetaLite®, which recently received 510(k) clearance from the US Food and Drug Administration.

In addition to the benefits for patients, an AI-powered 3D pathology platform that continuously grows could greatly accelerate biomarker research and benefit the healthcare industry. Over time, the platform could continue to grow more precise at cancer diagnosis as it learns from sample biomarkers paired with anonymized patient outcome data. Also, as the platform finds novel biomarkers, it could facilitate development of new technologies and their commercialization.

About JelloX Biotech Inc.

Based in Hsinchu, Taiwan, JelloX Biotech Inc. is a startup which focus on advancing cancer pathology through 3D digital imaging and AI technology. 

For more information, please visit: https://jellox.com/en/home/

Samsung Biologics reports fourth quarter and fiscal year 2024 financial results

  • Recorded Q4’24 consolidated revenue of KRW 1.26 trillion
  • Recorded FY’24 consolidated revenue of KRW 4.55 trillion
  • Poised for further growth with expanded capacity and new service offerings

INCHEON, South Korea, Jan. 22, 2025 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the fourth quarter and fiscal year 2024.

“2024 has been a year of steady progress for Samsung Biologics as we expanded collaboration with both pharma and biotech companies, supported by our focus on operational and quality excellence,” said John Rim, CEO and President of Samsung Biologics. “We have been able to continue delivering on our commitments by investing in capacity, modality, and geographic expansion. We expect another year of growth through the opening of Plant 5, launch of ADC services, and continued investment in innovative technologies and sustainability. These efforts will enable us to better address the evolving needs of our clients at the right time.”

FOURTH QUARTER & FISCAL YEAR 2024 RESULTS

In the fourth quarter of 2024, Samsung Biologics achieved a consolidated revenue of KRW 1.26 trillion while operating profit stood at KRW 325.7 billion. This growth was driven by the increased contribution from Plant 4 and full utilization of Plants 1 through 3.

Full-year 2024 consolidated revenue was at KRW 4.55 trillion, a 23% increase from KRW 3.69 trillion in 2023. Operating profit increased by 19%, totaling to KRW 1.32 trillion.

[Consolidated Earnings, KRW billion] 

Q4’24

Q4’23

YoY

Change

FY24

FY23

YoY

Change

Revenue

1,256.4

1,073.5

+182.9

(+17.0%)

4,547.3

3,694.6

852.7

(+23.1%)

Operating
Profit

325.7

350.0

-24.3

(-6.9%)

1,320.1

1,113.7

206.4

(+18.5%)

EBITDA

476.5

491.9

-154

(-3.1%)

1,919.2

1,603.5

315.7

(+19.7%)

On a standalone basis, Samsung Biologics recorded a revenue of KRW 3.50 trillion and an operating profit of KRW 1.32 trillion in 2024. In the fourth quarter of 2024 alone, the company posted a revenue of KRW 950.4 billion and an operating profit of KRW 314.7 billion.

Samsung Biologics has served over 110 clients, including 17 of the worlds’ top pharma companies, reinforcing its position as a trusted partner in the biopharmaceutical industry. These partnerships supported the company in surpassing a total contract value of USD 4.3 billion in 2024, contributing to a cumulative contract value of USD 16.3 billion. The company achieved 340 regulatory approvals as of December 2024, underscoring its commitment to quality and operational excellence.

FISCAL YEAR 2025 OUTLOOK

Full Plant 4 operations are expected to drive further revenue growth, while Plant 5 at Bio Campus II, scheduled to begin operations in April 2025, will expand the company’s total production capacity to 784,000 liters. The company is also considering the construction of a sixth plant to proactively respond to the growing demand for biologics, which would increase total production capacity to 964,000 liters upon board approval.

The dedicated ADC facility will address the growing need for ADC-based therapeutics by supporting the delivery of next-generation biomedicines. Additionally, the company’s innovative platforms S-HiCon™, S-Tensify™, S-AfuCHO™, and S-OptiCharge™ will offer clients enhanced flexibility, productivity, and quality for successful drug development.

Samsung Biologics plans to further optimize operational efficiency and project timelines by investing in AI and digital transformation to automate systems and facilities. The company is also expanding its drug product (DP) capabilities, with a fully automated pre-filled syringe DP line projected to be CGMP-ready by 2027.

Samsung Biologics continues to actively advance sustainability efforts. As a member of the Sustainable Markets Initiative’s Health Systems Task Force, the company is committed to developing practical guidelines for decarbonizing healthcare supply chains in collaboration with global leaders in public and private health sectors. By strengthening partnerships with suppliers and incorporating ESG principles into the value chain, Samsung Biologics aims to drive meaningful progress in its sustainability initiatives.

About Samsung Biologics Co., Ltd.

Samsung Biologics (KRX: 207940.KS) is a fully integrated, end-to-end CDMO service provider, offering seamless development and manufacturing solutions from cell line development to final aseptic fill/finish as well as laboratory testing support for the biopharmaceutical products we manufacture. Our state-of-the-art facilities are CGMP compliant with bioreactors ranging from small to large scales to serve varying client needs. Maximizing operational efficiency and expanding our capabilities in response to growing biomanufacturing demand, Samsung Biologics offers a combined 604 kL total capacity at Bio Campus I. The company launched Bio Campus II with the construction of Plant 5, which will be operational in April 2025, adding 180 kL biomanufacturing capacity. Additionally, Samsung Biologics America enables the company to work in closer proximity to clients based in the U.S. and Europe. We continue to upgrade our capabilities to accommodate our clients by investing in an ADC facility, mRNA technologies, and additional aseptic filling capacity. As a sustainable CDMO partner of choice, we are committed to on-time, in-full delivery of the products we manufacture with our flexible manufacturing services, operational excellence, and proven expertise.

Samsung Biologics Contact
Claire Kim, Head of Global Marketing Communications
cair.kim@samsung.com 

2025 Japan Prize Laureates Announced

TOKYO, Jan. 22, 2025 /PRNewswire/ — The Japan Prize Foundation announced the winners of the 2025 Japan prize on January 22, 2025. Prof. Russell Dean Dupuis of the USA has been awarded the Japan Prize in the fields of Materials Sciences and Production, and Prof. Carlos M. Duarte of Spain has been awarded the Japan Prize in the fields of Biological Production, Ecology/Environment.

– Field Eligible for the Award: Materials Sciences and Production
Prof. Russell Dean Dupuis
Image:
https://cdn.kyodonewsprwire.jp/prwfile/release/M000319/202501152911/_prw_PI1fl_tS7bGu5Q.jpg

– Field Eligible for the Award: Biological Production, Ecology/Environment
Prof. Carlos M. Duarte
Image:
https://cdn.kyodonewsprwire.jp/prwfile/release/M000319/202501152911/_prw_PI2fl_75vq5Xm9.jpg

For this year’s Japan Prize, Prof. Dupuis is being recognized for his distinguished contributions to the development of metalorganic chemical vapor deposition technology for compound semiconductor electronic and optoelectronic devices, and pioneering contribution to its large-scale commercialization; and Prof. Duarte is being recognized for his contribution to the understanding of marine ecosystems in a changing Earth, especially through pioneering research on Blue Carbon.

For the 2025 Japan Prize, the Foundation asked approximately 15,500 prominent scientists and engineers from around the world to nominate researchers working in this year’s fields. It received 149 nominations for the fields of Materials Sciences and Production, and 72 nominations for the fields of Biological Production, Ecology/Environment. This year’s winners were selected from a total of 221 nominees.

About the Japan Prize

The establishment of the Japan Prize in 1981 was motivated by the Japanese government’s desire to create an internationally recognized award that would contribute to scientific and technological development around the world. With the support of numerous donations, the Japan Prize Foundation received endorsement from the Cabinet Office in 1983.

The Japan Prize is awarded to scientists and engineers from around the world who have made creative and dramatic achievements that help progress their fields and contribute significantly to realizing peace and prosperity for all humanity. Researchers in all fields of science and technology are eligible for the award, with two fields selected each year in consideration of current trends in scientific and technological development. In principle, one individual in each field is recognized with the award, and receives a certificate, a medal, and a monetary prize. Each Award Ceremony is attended by the reigning Emperor and Empress, heads of the three branches of government and other related officials, and representatives from various other elements of society.

For more information, please visit the official website: https://www.japanprize.jp/en/index.html

CP AXTRA Partners with Tencent Cloud: Catalysing a Digital Transformation in Retail

Newly signed agreement encompasses IaaS and artificial intelligence solutions to enhance customer experience, competitive edge and operational capabilities

BANGKOK, Jan. 22, 2025 /PRNewswire/ — Tencent Cloud and CP AXTRA unveiled a strategic collaboration with the goal of accelerating digital transformation in retail. Leveraging Tencent Cloud’s cutting-edge cloud-based infrastructure and AI-driven solutions in bolstering digital capabilities, CP AXTRA aims to enhance customer experience and operational efficiency, as well as improve its business outcomes.

The MoU was signed by Mr. Jimmy Chen, Vice President of Tencent Cloud International and Managing Director of Southeast Asia (right), and Mr. Tarin Thaniyavarn, Group Chief Technology & Data Officers and Group Chief E-Commerce Officer, CP AXTRA Public Company Limited (left).
The MoU was signed by Mr. Jimmy Chen, Vice President of Tencent Cloud International and Managing Director of Southeast Asia (right), and Mr. Tarin Thaniyavarn, Group Chief Technology & Data Officers and Group Chief E-Commerce Officer, CP AXTRA Public Company Limited (left).

CP AXTRA, is an operator of Asia’s leading B2B and B2C retailers, Makro and Lotus’s, based in Thailand, with operation across 10 countries. Over 30 years of wholesale and retail experience, CP AXTRA is a trusted partner for customers, offering a comprehensive range of products and services. Today, it manages over 2,600 offline stores in Thailand and Asia, with strong online presence.

To enhance its service offerings, CP AXTRA has entered a strategic partnership with Tencent Cloud, aiming to accelerate digital transformation and adopt AI technologies across the company. This collaboration leverages Tencent Cloud’s profound expertise in industry-specific solutions, coupled with comprehensive support from its team of industry experts to drive CP AXTRA’s digital journey.

To formalize the partnership, a Memorandum of Understanding (MoU) ceremony was held in Bangkok, attended by high-level representatives from Tencent Cloud International and CP AXTRA. The MoU was signed by Mr. Jimmy Chen, Vice President of Tencent Cloud International and Managing Director of Southeast Asia, and Mr. Tarin Thaniyavarn, Group Chief Technology & Data Officers and Group Chief E-Commerce Officer, CP AXTRA Public Company Limited. The ceremony was also witnessed by Mr. Zhang Yun Ming, Deputy Minister from the Ministry of Industry and Information Technology China, and Mr. Prasert Jantararuangtong, Deputy Prime Minister and Minister of Digital Economy and Society of Thailand.

The partnership encompasses Tencent Cloud’s Infrastructure-as-a-Service (IaaS) and artificial intelligence solutions to enhance CP AXTRA’s efficiency across various business aspects, including assortment range optimization, demand forecasting, pricing and promotions analysis, with the aim to elevate customer experience.

Looking ahead, CP AXTRA and Tencent Cloud are also exploring opportunities to leverage AI solutions and machine learning tools for sales forecasting and warehouse management.

Poshu Yeung, Senior Vice President, Tencent Cloud International, said, “Tencent Cloud is pleased to further solidify our presence in the retail sector by adding CP AXTRA, another major top-tier retailer, to our portfolio. We look forward to helping CP AXTRA boost its digitalization and AI efforts through our highly reliable and high-quality solutions, products and services with the goal of bolstering the retail leader’s business outcomes.”

Tarin Thaniyavarn, Group Chief Technology & Data Officers and Group Chief E-Commerce Officer, CP AXTRA Public Company Limited, said, “CP AXTRA is glad to be partnering with Tencent Cloud, benefiting from its cutting-edge IaaS and AI solutions. This partnership underscores our commitment to using top-tier technology to enhance our customer experience, competitive edge and operational capabilities, reinforcing our retail leadership in the region.”

About Tencent Cloud

Tencent Cloud, one of the world’s leading cloud companies, is committed to creating innovative solutions to resolve real-world issues and enabling digital transformation for smart industries. Through our extensive global infrastructure, Tencent Cloud provides businesses across the globe with stable and secure industry-leading cloud products and services, leveraging technological advancements such as cloud computing, Big Data analytics, AI, IoT and network security. It is our constant mission to meet the needs of industries across the board, including the fields of gaming, media and entertainment, finance, healthcare, property, retail, travel and transportation.

About CP AXTRA

CP AXTRA Public Company Limited, is an operator of Asia’s leading wholesaler and retailer, Makro and Lotus’s. The Company is based in Thailand, with operation across 10 countries. CP AXTRA is committed to fulfilling people’s lives with good health, love, joy, and well-being, by providing solutions and meeting customers’ daily needs with technology, innovation, and operational excellence.

With over 30 years of retail experience, CP AXTRA is a trusted partner for both B2B and B2C customers, offering a comprehensive range of products and services. Today, it manages over 2,600 offline stores in Thailand and Asia, with strong online presence.

Akeso Received Payment for the Development Collaboration on Tagitanlimab

HONG KONG, Jan. 22, 2025 /PRNewswire/ — On January 22, 2025, Akeso Inc. (9926.HK) announced that it had received payment from Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. (“Sichuan Kelun”) for their collaboration on the development of tagitanlimab, an innovative humanized monoclonal antibody targeting PD-L1, following its recent marketing approval by China’s National Medical Products Administration.

In 2014, Akeso signed a cooperation agreement with Sichuan Kelun for the development of tagitanlimab. Under the terms of the agreement, Akeso will receive royalties from the commercial sales of tagitanlimab in addition to the development payment.

Tagitanlimab marks Akeso’s second oncology product to yield commercial royalties, following pucotenlimab, a PD-1 monoclonal antibody developed in collaboration with Lepu Biopharma in 2016.

Dr. Yu Xia, founder, chairwoman, president, and CEO of Akeso, said: “Congratulations to our partners. We are thrilled about continuously successful approval of our innovative products, and truly anticipate their outstanding commercialization performance. This achievement highlights Akeso’s strong R&D capabilities and our commitment to innovation. Since its inception, Akeso has established multiple external collaborations, including ivonescimab with Summit Therapeutics, quavonlimab with Merck and pucotenlimab with Lepu Biopharma. These partnerships not only benefit patients but also deliver significant returns for both Akeso and our collaborators. Looking ahead, Akeso will continue to pursue a diversified strategy for new drug development, leveraging global resources to drive the high-quality commercialization of our independently developed innovative therapeutics.”

To answer three key questions about economic globalization

BEIJING, Jan. 22, 2025 /PRNewswire/ — A report from People’s Daily: In the face of a sluggish world economic recovery, the rising threat of protectionism, and the widening gap between the rich and the poor, discussions around economic globalization are increasing within the international community. At the center of discussion, there are three main questions as follows.

Has economic globalization stagnated or regressed?

Economic globalization has not stagnated or regressed, but continues to develop against headwinds.

According to the Global Trade Update published by the United Nations Conference on Trade and Development (UNCTAD), global trade is on track to hit a record $33 trillion in 2024, marking a 3.3 percent annual growth. It has demonstrated strong resilience, largely driven by digital trade and trade in services.

The overall global landscape shows that businesses around the world continue to thrive within the interconnected supply, industrial and value chains. The World Openness Report 2024 indicates that the rise and evolution of global value chains reflect the inherent rationale of economic globalization, which is driven by digitalization, green economy, and services sector.

Globally, political consensus and policy measures to promote open development are steadily increasing.

The high-quality implementation of the Regional Comprehensive Economic Partnership (RCEP) has delivered increasingly prominent development dividends to member countries. The Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) has not waned despite the withdrawal of a few countries; instead, it has attracted more countries to join.

African countries are accelerating the implementation of the African Continental Free Trade Area (AfCFTA), which was enacted in several African nations, including South Africa, Ghana, and Kenya in 2024. The 31st APEC Economic Leaders’ Meeting also reached an important consensus on upholding the multilateral trading system and advancing regional economic integration.

How to view the headwinds and undertows facing economic globalization?

Despite headwinds and undertows, economic globalization has always been the general trend.

Historically, the global economy was thrown into disarray by two world wars, which severed international trade routes. The subsequent nearly half-century-long Cold War divided the world into two distinct camps, hindering economic exchanges and disrupting the flow of resources.

However, in the long run, these disruptions did not prevent the world from returning to the path of economic globalization. This is because economic globalization is an objective requirement of growing social productive forces and a natural outcome of advancement in science and technology – a fact that no one can change.

The current headwinds against economic globalization are largely a result of political shifts within a few countries and do not signify a change in the fundamental logic that economic globalization promotes global welfare.

According to the World Trade Organization (WTO), between 1996 and 2021, a high trade share of GDP was strongly linked to faster economic growth in low- and middle-income economies. This fully proves that openness is the only path toward prosperity and development for every country.

Today, the world is moving faster to embrace a digital, green and smart economy, building up powerful energy for further expedition of economic globalization down the road.

WTO statistics show that the global exports of digitally delivered services reached $4.25 trillion in 2023, up nine percent year-on-year, accounting for a record 54.2 percent of world services exports.

Besides, green and sustainable development has become a global consensus, with global annual renewable capacity additions increasing by almost 50 percent in 2023.

Mark Leonard, director of the European Council on Foreign Relations, noted that due to accelerated reforms in energy and technology, the world is experiencing “re-globalization” rather than “de-globalization.”

How to resolve the issues and challenges brought by economic globalization?

Economic globalization is at a new crossroads. It must be guided carefully to maximize its benefits and ensure its sound and sustainable development.

The World Trade Report 2024 warns that mounting protectionism threatens to unwind 30 years of progress in closing income gaps between poor and rich countries. Both the United Nations and the International Monetary Fund have recently cautioned that rising tariffs could hamper global economic growth. All countries, especially major economies, should uphold the general trend of open development, resist protectionism, and build an open world economy.

To resolve the challenges brought by economic globalization, the key lies in promoting universally beneficial, inclusive economic globalization. It is important to address the development imbalances between and within countries resulting from the global allocation of resources, and ensure that different countries, classes, and communities can all participate in and benefit from economic and social development, so as to take economic globalization to a new phase that is more dynamic, inclusive, and sustainable. This requires wisdom and decisive action from governments of all countries.

China has blazed a development path of pursuing common development through opening up. Its active participation in economic globalization has not only driven its own development but also provided immense development opportunities to other countries.

China’s experience demonstrates that promoting universally beneficial, inclusive economic globalization can contribute to shared development of all countries in the world. This is why China is committed to pursuing a mutually beneficial strategy of opening up, expanding voluntary and unilateral opening up in an orderly manner, steadily expanding institutional opening up, and pushing for an open world economic system.

Economic globalization is a sure way for human society to achieve development and an irreversible trend of the times. All countries must possess the wisdom to recognize this overarching trend, and the determination and confidence to work with it, so as to join hands in promoting universally beneficial, inclusive economic globalization.

The 7th “HK Digital Advertising Start-ups X Publishing (Writers) Promotion Support Scheme”

Unveiling 12 Selected Teams of Local Digital Advertising Start-ups & Emerging Writers

HONG KONG, Jan. 22, 2025 /PRNewswire/ — The Hong Kong Digital Advertising Start-ups X Publishing (Writers) Promotion Support Scheme (the “Support Scheme”), organized by Hong Kong Association of Interactive Marketing (“HKAIM”), and supported by the Cultural and Creative Industries Development Agency (“CCIDA”) of the Government of the Hong Kong Special Administrative Region (“HKSAR Government”) as the lead sponsor, has been nurturing local digital advertising start-ups since its inception in 2018. By providing funding and professional training, the Support Scheme enables these start-ups to design bespoke digital advertising campaigns for local emerging writers, promoting their designated works. The initiative fosters cross-sectoral collaboration between emerging writers, the publishing industry, and the digital advertising industry, creating more opportunities for growth and development.

Guests of Honor took a group photo with the selection committee members, judges, mentors, 12 groups of selected emerging writers and publishers, and representatives of 12 selected local digital advertising start-ups to conclude the Launch Ceremony.
Guests of Honor took a group photo with the selection committee members, judges, mentors, 12 groups of selected emerging writers and publishers, and representatives of 12 selected local digital advertising start-ups to conclude the Launch Ceremony.

Entering its 7th edition, the Support Scheme received overwhelming response to its call for applications which was closed in late 2024, with 50 digital advertising start-ups and 21 emerging writers. The HKAIM has selected among the applicants and paired up 12 teams, each comprises a digital advertising start-up and an emerging writer. The designated books of applied emerging writers cover a wide range of topics, including education, sports, spirituality, history, music, counseling, science, workplace, comics, picture books, and more. The diversity would stimulate more creativities from the digital advertising start-ups as they plan the related campaigns.

The HKAIM successfully kicked off the 7th Support Scheme with a Launch Ceremony at Seminar Hall, Xiqu Centre on 20 January. Mr. Alex So, Head (Multi-media) of CCIDA, was invited to be the Guest of Honor. Along with him, Chairman of the HKAIM Mr. Francis Fong and Vice Chairman of Hong Kong Publishing Federation Mr. William So launched this year’s Support Scheme by announcing the 12 participating teams. (Full list below)

Each digital advertising start-up will receive a subsidy of up to HK$260,000 to design, plan and execute a digital advertising campaign for the designated book of the matched emerging writer. In addition, the HKAIM will provide training by industry experts, helping them to improve the creative concept and execution of their digital advertising campaigns. The Support Scheme not only creates an opportunity for the digital advertising and publishing industries to collaborate, it also promotes Chinese books through viral digital campaigns and cultivates a more robust reading culture.

In addition, the HKAIM will promote the participating digital advertising startups and emerging writers along with the selected books through a wide range of promotion channels including the Support Scheme’s official website, internet, social media, etc. For the 11 digital advertising projects created under last year’s (the 6th) Support Scheme, the campaigns reached nearly 19.56 million people, with nearly 1.33 million engagements, and almost 7.38 million views, successfully bringing attention to the selected books by the emerging writers, and delivering accurate messages from the books to the target audience, creating more opportunities for readers and emerging writers to interact and communicate. The HKAIM is optimistic that this year’s Support Scheme will achieve similarly stellar results.

The HKAIM will also host a booth at Hong Kong Book Fair 2025 in July to showcase the 12 digital advertising campaigns and the designated books. The Digital Advertising Design (for Publishing) Awards Competition and Presentation Ceremony will also be scheduled to recognize the best digital advertising campaign among the 12 as determined by industry experts. The “My Favourite Digital Advertising (for Publishing) Award” based on public voting, will also be presented at the ceremony. The Presentation Ceremony will highlight digital advertising campaigns as well as recognize the efforts of the participating teams.

The HKAIM will post regular updates about the Support Scheme and the 12 teams on our official website and Facebook page. For more details about the Support Scheme, please visit:

Official website: www.digiad.hk
Facebook page: www.facebook.com/AdxPub
Instagram page: www.instagram.com/adxpub_hk

Organizer: The Hong Kong Association of Interactive Marketing
Lead Sponsor: The Cultural and Creative Industries Development Agency of the Government of the Hong Kong Special Administrative Region

Disclaimer: The Government of the Hong Kong Special Administrative Region provides funding support to the project only, and does not otherwise take part in the project. Any opinions, findings, conclusions or recommendations expressed in these materials/events (or by members of the project team) are those of the project organisers only and do not reflect the views of the Government of the Hong Kong Special Administrative Region, the Culture, Sports and Tourism Bureau, the Cultural and Creative Industries Development Agency, the CreateSmart Initiative Secretariat or the CreateSmart Initiative Vetting Committee.

The 12 selected pairs of digital advertising start-ups and emerging writers for the 7th Support Scheme are listed in alphabetical order (according to Start-up) as follows:

Local Digital Advertising Start-up (ENG)

Local Digital Advertising Start-up (CHI)

Publisher

Local New and Emerging Writers (English Name)

Designated Book (Chinese Title)

Designated Book (English Title, if any)

1

At This Moment

n/a

Breakthrough Limited

Wing Yuek Ching

鐡人1.5

One Half

2

FROM THE TOP PRODUCTION LIMITED

優本製作有限公司

Boaz International Education Institute Limited

Chan Cheuk Ki Twiggy,

Shum Yin Wah

我不是笨笨

n/a

3

Gain Tune International Limited

德通國際有限公司

SYRT Academy Company Limited

Yu Wing Kong, Steve

招募之RD

Recruit to RD

4

Hungerr Universe Limited

哼嘎制作有限公司

Ming’s Readers Publisher

Lai Wai Hang,

Li Lo

MBTI人際探險——不同性格類型一起生活,要如何相處?

n/a

5

Kangaroll Creative

n/a

HKEJ Publishing Limited

Cheung Ching Fung

港人防災必修科

n/a

6

Moisland

無島

City University of Hong Kong Press

Lin Ka Chun

被遺忘的香港管樂史

The Forgotten History of Wind Bands in Hong Kong

7

Nine Nine Digital

n/a

Sun Ya Publications (HK) Limited

Leung Tim

未來科學拯救隊3:碧月薄荷大謎團

Future Science Rescue Team (3): The Great Mystery of Green Lunar Mint

8

PI Consultancy & Training Company Limited

n/a

Enrich Publishing Limited

Miss Heart

校園療心室2——自主情緒‧實現真我

n/a

9

Ripple Vision

漣漪映畫

Quire Limited

Cheung Yu Ting (Ar Yu)

靈魂中轉站

SOULTOPIA

10

Storeroom No.9

玖號士多房

Lokrazy Plus Design

Kwan Wai Lok

(Nalok.lok)

可以給我/你一次機會嗎?

One Chance? One Chance.

11

Studio120

120工作室

Chinese Christian Literature Council Ltd

Cheung Ka Yan

神在野——香港山野靈思之旅

God in the wild: Awakening Spirituality in the nature of Hong Kong

12

Tinysotiny.co Limited

n/a

Cosmos Books Limited

Tsang, Mo-suet Musette Faye

的的撐撐開飯啦

n/a